|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation of premises and equipment, and amortization | |||||
| Amortization of intangible assets | |||||
| Provision for credit losses | |||||
| Amortization of investment securities premium, net | |||||
| Loss on sale of investment securities | |||||
| Originations of loans for resale | |||||
| Proceeds from sale of loans originated for resale | |||||
| Gain on sale of loans | |||||
| Change in fair market value of mortgage servicing rights | |||||
| Gain on extinguishment of junior subordinated debt | |||||
| Loss (gain) on sale of real estate owned, net | |||||
| Deferred income tax benefit (expense) | |||||
| Gain on transfer of loans to real estate owned | |||||
| Operating lease payments | |||||
| Loss on disposal of fixed assets | |||||
| Increase in cash value of life insurance | |||||
| Gain on life insurance death benefit | |||||
| Gain on marketable equity securities | |||||
| Equity compensation vesting expense | |||||
| Change in fair value of other real estate | |||||
| Amortization of operating lease right of use asset | |||||
| Change in: | |||||
| Interest receivable | |||||
| Interest payable | |||||
| Other assets and liabilities, net | |||||
| Net cash from operating activities | |||||
| Investing activities: | |||||
| Cash acquired in acquisition; net of consideration paid | |||||
| Maturities and principal repayments of securities available for sale | |||||
| Maturities and principal repayments of securities held to maturity | |||||
| Proceeds from sale of available for sale securities | |||||
| Purchases of securities available for sale | |||||
| Loan origination and principal collections, net | |||||
| Loans purchased | |||||
| Proceeds from sale of real estate owned | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchases of premises and equipment | |||||
| Life insurance proceeds | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Net change in deposits | |||||
| Net change in other borrowings | |||||
| Repayment of junior subordinated debt | |||||
| Repurchase of common stock, net | |||||
| Dividends paid | |||||
| Exercise of stock options | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of cash flow activity: | |||||
| Cash paid for interest expense | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of noncash activities: | |||||
| Unrealized gain (loss) on securities available for sale | |||||
| Loans transferred to foreclosed assets | |||||
| Market value of shares tendered in-lieu of cash to pay for exercise of options and/or related taxes | |||||
| Obligations incurred in conjunction with leased assets | |||||
Loading...
